INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 Diabetes
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to basal insulin
Related studies linked through entity extraction aliases.
A Study of LY3938577 in Healthy Participants and Participants With Type 1 Diabetes Mellitus (T1DM)
- Status
- RECRUITING
- Phase
- PHASE1
Impact of GLP-1 RAs Compared to Basal Insulin Start in Patients Living With Type 2 Diabetes and Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- N/A
INHALE-3: Afrezza® Combined With Insulin Degludec Versus Usual Care in Adults With Type 1 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
BESTMED: Observational Evaluation of Second Line Therapy Medications in Diabetes
- Status
- UNKNOWN
- Phase
- N/A
Afrezza® INHALE-1 Study in Pediatrics
- Status
- COMPLETED
- Phase
- PHASE3
A Study of A Novel Approach to Titrate Basal Insulin (LY2963016) in Participants With Type 2 Diabetes
- Status
- WITHDRAWN
- Phase
- PHASE4
Remote Study Collecting Blood Glucose Values and Activity Data in Patients With Type 2 Diabetes on Different Treatments
- Status
- COMPLETED
- Phase
- N/A
Clinical Outcomes of Exenatide Versus Basal Insulin
- Status
- COMPLETED
- Phase
- N/A
Comparison of the Effectiveness and Tolerability of Exenatide Once-weekly Compared to Basal Insulins
- Status
- COMPLETED
- Phase
- N/A
Safety Assessment of Lyxumia (Lixisenatide) and Sulfonylurea as Add-on Treatment to Basal Insulin in Uncontrolled Patients With Type 2 Diabetes Mellitus Who Elect to Fast During Ramadan
- Status
- COMPLETED
- Phase
- PHASE4
Subanalyses of Elderly Type 2 Diabetes Patients or Type 2 Diabetes Patients With Renal Impairment
- Status
- COMPLETED
- Phase
- N/A
Stepping-down Approach in Patients With Chronic Poorly-controlled Diabetes on Advanced Insulin Therapy?
- Status
- COMPLETED
- Phase
- NA
A Study on Safety, Pharmacokinetics and Pharmacodynamics of Lixisenatide in Pediatric Patients With Type 2 Diabetes Mellitus (T2DM)
- Status
- COMPLETED
- Phase
- PHASE1
A Study To Evaluate The Efficacy And Safety Of Ertugliflozin In Participants With Type 2 Diabetes Mellitus And Inadequate Glycemic Control On Metformin Monotherapy (MK-8835-007).
- Status
- COMPLETED
- Phase
- PHASE3
Vildagliptin/Metformin in T2DM Patients Starting Basal Insulin
- Status
- COMPLETED
- Phase
- PHASE3
Efficacy and Safety of FIAsp in a Basal-bolus Regimen Versus Basal Insulin Therapy, Both in Combination With Metformin in Adult Subjects With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE3
Exenatide and Basal Insulins Use in the Real Setting: an Observational Study in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- N/A
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin +/- Sulfonylurea (GETGOAL-L-ASIA)
- Status
- COMPLETED
- Phase
- PHASE3
GLP-1 Receptor Agonist Lixisenatide in Patients With Type 2 Diabetes for Glycemic Control and Safety Evaluation, on Top of Basal Insulin
- Status
- COMPLETED
- Phase
- PHASE3